Trillium Therapeutics Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Trillium Therapeutics Inc.
CIK #0001616212
EDGAR Form CIK 2011 - 2025
10-K [0001616212]
10-Q [0001616212]
3 [0001616212]
4 [0001616212]
6-K [0001616212]
8-K [0001616212]
D [0001616212]
SC 13D [0001616212]
SC 13G [0001616212]
Form 13D/13G Filer Form 13D/13G Subject Filed
RA Capital Management LP Trillium Therapeutics Inc [2021-02-16]
Avoro Capital Advisors LLC Trillium Therapeutics Inc [2021-02-12]
SIO Capital Management LLC Trillium Therapeutics Inc [2020-02-14]
Boxer Capital LLC Trillium Therapeutics Inc [2020-02-03]
Vivo Capital IX LLC Trillium Therapeutics Inc [2020-02-03]
Venrock Healthcare Capital Partners III LP Trillium Therapeutics Inc [2020-01-21]
Morgan Stanley Trillium Therapeutics Inc [2019-12-31]
Empery Asset Management LP Trillium Therapeutics Inc [2019-03-04]
Morgan Stanley Trillium Therapeutics Inc [2018-12-21]
AWM Investment Company Inc Trillium Therapeutics Inc [2018-02-13]
View All
Form 3/4/5 Subject 2011 - 2025
Skvarka Jan
Trillium Therapeutics Inc.
Walker Paul Edward
Pucci Paolo
Myers Scott Dunseth
Harrison Rosemary
Beshar Luke M
Parsons James T.
Kamarck Michael E.
Looker Benjamin
Mackey Catherine J
Bruns Ingmar
Petrova Penka
Uger Robert
Tayton-Martin Helen Katrina
Reynolds Thomas C
Kirkman Robert L
Terms | Privacy | Guide
tony@aum13f.com